Re: A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome

2019 ◽  
Vol 75 (3) ◽  
pp. 534
Author(s):  
Piotr Radziszewski ◽  
Łukasz Zapała
Sign in / Sign up

Export Citation Format

Share Document